Supported By: GlaxoSmithKline
Omni Boston at the Seaport – Momentum ABC
This live event will offer the immersive experience of in-person instruction delivered by subject matter experts and a patient advocate. Case-based dialogue will allow for an interactive discussion of the burden of RSV in adults, and best practices to discuss RSV vaccines and engage in shared decision-making with your patients.
For more information and to register, please visit: www.medscape.org/symposium/rsv-patient-vaccine
Target Audience
This educational activity is intended for an audience of pulmonologists, infectious disease specialists, primary care physicians, pharmacists, nurse practitioners, physician assistants, and other clinicians who treat patients with respiratory syncytial virus in the United States.
Goal Statement
The goal of this activity is for learners to be better able to engage in shared decision-making about the RSV vaccine with patients at risk of severe RSV disease.
Learning Objectives
Upon completion of this activity, participants will:
Have increased knowledge regarding the
Have greater competence related to
Demonstrate greater confidence in their ability to
For more information and to register, please visit: www.medscape.org/symposium/rsv-patient-vaccine
This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians.
Moderator: Taison D. Bell, MD, MBA
University of Virginia School of Medicine
Department of Medicine
Associate Professor
Charlottesville, VA
Presenter: Lilian M. Abbo, MD, MBA
University of Miami Miller School of Medicine
Professor of Clinical Infectious Diseases
Miami, FL
Presenter: Abisola Olulade, MD
Chief Impact Officer
Sharp Rees Steely Medical Centers
San Diego, CA